Antibodies to vaccine antigens in pooled polyclonal human IgG products-Reference-Cited by-同舟云学术

Antibodies to vaccine antigens in pooled polyclonal human IgG products

Published:2018-12 Issue:S3 Volume:58 Page:3096-3105
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Berger Melvin¹

Affiliation:

1. Global Medical Affairs, CSL Behring, LLC King of Prussia Pennsylvania

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15017

Reference55 articles.

1. United States Food and Drug Administration (2008) Guidance for industry: safety efficacy and pharmacokinetic studies to support marketing of immune globulin intravenous (human) as replacement therapy for primary humoral immunodeficiency. Available online at:https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm078526.pdf

2. Practice parameter for the diagnosis and management of primary immunodeficiency

3. RH Buckley

4. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies

5. Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy;2021-05-11

2. Antibodies to vaccine-preventable infections after CAR-T-cell therapy for B-cell malignancies;JCI Insight;2021-04-29

3. Antimicrobials;Understanding Pharmacology in Nursing Practice;2020

4. Assuring immune globulin potency in a world of changing pathogen challenges;Transfusion;2018-12